News Health & Medicine

Ozempic’s key ingredient may reduce the desire to drink alcohol

A small study shows heavy drinkers drank less while taking semaglutide

Glass bottles of alcohol sit on a shelf.

Semaglutide, a key ingredient in the popular weight-loss and diabetes treatments Wegovy and Ozempic, might reduce alcohol intake, a small clinical trial suggests.

DuKai photographer/Moment/Getty Images Plus

By Laura Sanders

A popular diabetes and weight-loss drug reduced people’s craving for drinking alcohol.

The results, from the first clinical trial of its kind, suggest that semaglutide may hold promise as a treatment for problematic alcohol use.